tbuckley/cabot-search huggingface dataset:
88P Genetic platforms in hormone receptor (HR)+ early breast cancer (eBC): Could logistic regression models be used instead?
Authors: A. Lopez Paradis, A. Pous, L. Notario Rincon, G. Cerdà Sebastià, M. Sant Albors, M.A. Bergamino, A. Ferrando Diez, I. Teruel-Garcia, M. Romeo Marin, V. Quiroga Garcia, B. Cirauqui Cirauqui, M. Margeli Vila, E. Felip Falgas
Journal: Annals of Oncology (2022)
IS CAPSULE ENDOSCOPY SMALL BOWEL ANGIODYSPLASIA ACTIVITY INDEX (CESBAI) CAPABLE OF PREDICTING REBLEEDING AND NEED FOR ENDOSCOPIC TREATMENT IN PATIENTS WITH SUSPECTED SMALL BOWEL BLEEDING?
Authors: T. Lima Capela, V. Macedo Silva, M. Freitas, C. Arieira, S. Xavier, T. Cúrdia Gonçalves, P. Boal Carvalho, B. Rosa, M. João Moreira, J. Cotter
Journal: Endoscopy (2022)

Aims The Capsule Endoscopy Small Bowel Angiodysplasia Activity Index (CESBAI) is a recently created score for small bowel angiodysplasias (SBAD) evaluation in patients with suspected small bowel bleeding (SBB), including 3 variables: extension, number and bleeding probability of SBAD. Although having a low interobserver variability, it is still unknown if it could be used in the prediction of rebleeding and need for endoscopic treatment after initial capsule endoscopy (CE). We aimed to evaluate the performance of CESBAI for these outcomes.
DIAGNOSTIC YIELD OF ENDOSCOPIC ULTRASOUND IN THE EVALUATION OF UNEXPLAINED COMMON BILE DUCT DILATATION ON CROSS-SECTIONAL IMAGING
Authors: H. Koulali, A. Zazour, G. Kharrasse, Z. Ismaili, W. Khannoussi
Journal: Endoscopy (2022)

Aims evaluate the diagnostic performance of EUS unexplained dilated CBD on cross-sectional imaging (CSI)
THREE-DIMENSIONAL (3D) ENDOSCOPIC SLEEVE GASTROPLASTY: SINGLE CENTER CASE SERIES
Authors: M. Afonso, R. Soares, R. Ramos, J. Balkesthahl, E. Andrade, L. Machado
Journal: Endoscopy (2022)

Aims To evaluate the use 3D endoscopic visualization system to perform endoscopic sleeve gastroplasty
IATROGENIC COLONIC PERFORATION CLOSURE WITH AN OVER-THE-SCOPE CLIP APPLIED WITH GASTROSCOPE FOUR HOURS UPON INDEX COLONOSCOPY: A CASE REPORT
Authors: P. Nicolaou, M. Velegraki, D. Arna, A. Psistakis, E. Bachlitzanakhs, M. Flamourakis, G. Paspatis
Journal: Endoscopy (2022)

A 71-year-old female was referred to our unit due to a perforation at the sigmoid colon, endoscopically diagnosed 4 hours earlier during a screening colonoscopy, which was initially treated with conventional clipping. The closure was not considered secure by the endoscopist and the patient was referred to our unit. We decided to proceed with a new colonoscopy. An approximately 1.5 cm defect was identified and its closure was attempted using an OTSC​ mounted on a colonoscope, which was impossible due to pelvic adhesions. The attempt was continued and an OTSC​ was mounted on a gastroscope. The clip was successfully applied.
LONG-TERM EFFICACY AND GASTROESOPHAGEAL REFLUX DISEASE AFTER PER ORAL ENDOSCOPIC MYOTOMY (POEM): A PROSPECTIVE STUDY WITH 5-YEARS OBJECTIVE FOLLOW-UP
Authors: E. Vespa, R. Maselli, G. Pellegatta, P.A. Galtieri, E. Carlani, A. Capogreco, M. Spadaccini, R. Nicoletti, V. Craviotto, P. Omodei, A. Anderloni, A. Fugazza, S. Carrara, E.C. Ferrara, C. Hassan, A. Repici
Journal: Endoscopy (2022)

Aims Peroral endoscopic myotomy (POEM) has shown excellent short-term safety and efficacy; long-term data are limited. Aim of the study was to assess durability of POEM efficacy and long-term GERD evolution.
OUTCOMES OF COMBINED MANAGEMENT BILIARY AND GASTRIC OUTLET OBSTRUCTION (CABRIOLET STUDY): A MULTICENTRE RETROSPECTIVE ANALYSIS
Authors: G. Vanella, M. Bronswijk, R.L. van Wanrooij, G. Dell'Anna, W. Laleman, H. van Malenstein, R.P Voermans, P. Fockens, S. van der Merwe, P.G. Arcidiacono
Journal: Endoscopy (2022)

Aims Combined Biliary (BO) and Gastric Outlet Obstruction (GOO) is a challenging scenario, even in the era of therapeutic EUS, as GOO might reduce the clinical success of EUS-guided biliary drainage. Little is known on post-procedural dysfunction-free survival (DFS) of different combinations used to treat double obstruction (DO).
ENDOSCOPIC VACUUM THERAPY (EVT) FOR THE CLOSURE OF UPPER GASTROINTESTINAL DEFECTS: PRELIMINARY RESULTS FROM THE SPANISH EVT REGISTRY
Authors: O. Sendino, A. Fernandez-Simon, D. Busquets, A. Zebenzuy, J. García-Lledó, J. Tejedor-Tejada, E. Rodríguez de Santiago, F. Junquera, M. Moris, D. Juzgado, E. Ferrero, C. Garrido, J. Gornals, C. Guarner-Argente, A. Repiso, J.M. Esteban, S. González, A. Seoane, H. Cordova, A. Cardenas, B. Gonzalez-Suarez, D. Momblan, A. de Lacy
Journal: Endoscopy (2022)

Methods In November 2018, a Spanish registry of patients with upper gastrointestinal tract defects who underwent EVT using Eso-SPONGE was initiated. All demographic, clinical and technical variables related to the procedure were collected in a Redcap-type database. The patients were followed for 6 months to assess the persistence of the closure and/or the appearance of adverse events.
EFFICACY AND SAFETY OF ENDOSCOPIC ULTRASOUND-GUIDED HEPATICO-GASTROSTOMY: A META-REGRESSION ANALYSIS
Authors: C. Binda, E. Dajti, A. Cucchetti, C. Coluccio, A. Repici, A. Anderloni, G. Ercolani, C. Fabbri
Journal: Endoscopy (2022)

Aims EUS-guided hepaticogastrostomy (EUS-HGS) is valid option of EUS-guided biliary drainage that has been increasingly used in the last ten years. Aims of the study were to provide a systematic review with meta-analysis and meta-regression of features and outcomes after this procedure.
29P The molecular landscape of breast mucoepidermoid carcinoma
Authors: N. Fusco, K. Venetis, E. Sajjadi, M. Ivanova, S. Andaloro, S. Pessina, C. Zanetti, G. Citelli, C. Rossi, M. Lucioni, U. Malapelle, F. Pagni, M. Barberis, E. Guerini-Rocco, G. Viale
Journal: Annals of Oncology (2022)
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Authors: Buel D Rodgers, Christopher W Ward
Journal: Endocrine Reviews (2021)

Muscle wasting disease indications are among the most debilitating and often deadly noncommunicable disease states. As a comorbidity, muscle wasting is associated with different neuromuscular diseases and myopathies, cancer, heart failure, chronic pulmonary and renal diseases, peripheral neuropathies, inflammatory disorders, and, of course, musculoskeletal injuries. Current treatment strategies are relatively ineffective and can at best only limit the rate of muscle degeneration. This includes nutritional supplementation and appetite stimulants as well as immunosuppressants capable of exacerbating muscle loss. Arguably, the most promising treatments in development attempt to disrupt myostatin and activin receptor signaling because these circulating factors are potent inhibitors of muscle growth and regulators of muscle progenitor cell differentiation. Indeed, several studies demonstrated the clinical potential of "inhibiting the inhibitors," increasing muscle cell protein synthesis, decreasing degradation, enhancing mitochondrial biogenesis, and preserving muscle function. Such changes can prevent muscle wasting in various disease animal models yet many drugs targeting this pathway failed during clinical trials, some from serious treatment-related adverse events and off-target interactions. More often, however, failures resulted from the inability to improve muscle function despite preserving muscle mass. Drugs still in development include antibodies and gene therapeutics, all with different targets and thus, safety, efficacy, and proposed use profiles. Each is unique in design and, if successful, could revolutionize the treatment of both acute and chronic muscle wasting. They could also be used in combination with other developing therapeutics for related muscle pathologies or even metabolic diseases.
THE CASE OF A SCRUTINIZED UNUSUAL DUODENAL TUMOR : ESD RESECTION IN A DIAGNOSTIC AND CURATIVE AIM
Authors: M. Poiraud, F. Moulart, L. Verset, P. Eisendrath, A. Lemmers
Journal: Endoscopy (2022)

Prediction of subepithelial lesions (SEL) based on classical endoscopic appearance is often difficult.
ENDOSCOPIC-RADIOLOGIC RENDEZ-VOUS CHOLEDOCHAL RECONSTRUCTION FOR THE TREATMENT OF POST-SURGICAL COMMON BILE DUCT TRANSECTION
Authors: D. Costa, A. Tringali, G. Greco, R. Lanocita, M. Cosimelli, V. Mazzaferro
Journal: Endoscopy (2022)

A 76-year-old female presented complete choledochal transection (E3 Strasberg) after combined cytoreductive surgery with Hyperthermic Intra Peritoneal Chemotherapy for Pseudomyxoma Peritonei.
QUANTITATIVE ANALYSIS OF PERFUSION PATTERN IN CONTRAST-ENHANCED ENDOSCOPIC ULTRASONOGRAPHY FOR DIFFERENTIATION OF PANCREATIC TUMORS
Authors: M. Razpotnik, S. Bota, C. Urak, G. Essler, J. Weber-Eibel, M. Peck-Radosavljevic
Journal: Endoscopy (2022)

Aims Contrast-enhanced endoscopic ultrasound (CE-EUS) is a useful method for characterizing solid pancreatic tumors. We aimed to investigate the accuracy of quantitative analysis of enhancement patterns of solid pancreatic lesions to differentiate adenocarcinomas from other pancreatic tumors.
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma
Authors: Parvathi Sudha, Aarif Ahsan, Cody Ashby, Tasneem Kausar, Akhil Khera, Mohammad H. Kazeroun, Chih-Chao Hsu, Lin Wang, Evelyn Fitzsimons, Outi Salminen, Patrick Blaney, Magdalena Czader, Jonathan Williams, Mohammad I. Abu Zaid, Naser Ansari-Pour, Kwee L. Yong, Frits van Rhee, William E. Pierceall, Gareth J. Morgan, Erin Flynt, Sarah Gooding, Rafat Abonour, Karthik Ramasamy, Anjan Thakurta, Brian A. Walker
Journal: Clinical Cancer Research (2022)

Abstract Purpose: We designed a comprehensive multiple myeloma targeted sequencing panel to identify common genomic abnormalities in a single assay and validated it against known standards. Experimental Design: The panel comprised 228 genes/exons for mutations, 6 regions for translocations, and 56 regions for copy number abnormalities (CNA). Toward panel validation, targeted sequencing was conducted on 233 patient samples and further validated using clinical FISH (translocations), multiplex ligation probe analysis (MLPA; CNAs), whole-genome sequencing (WGS; CNAs, mutations, translocations), or droplet digital PCR (ddPCR) of known standards (mutations). Results: Canonical immunoglobulin heavy chain translocations were detected in 43.2% of patients by sequencing, and aligned with FISH except for 1 patient. CNAs determined by sequencing and MLPA for 22 regions were comparable in 103 samples and concordance between platforms was R2 = 0.969. Variant allele frequency (VAF) for 74 mutations were compared between sequencing and ddPCR with concordance of R2 = 0.9849. Conclusions: In summary, we have developed a targeted sequencing panel that is as robust or superior to FISH and WGS. This molecular panel is cost-effective, comprehensive, clinically actionable, and can be routinely deployed to assist risk stratification at diagnosis or posttreatment to guide sequencing of therapies.
TRADITIONAL VERSUS HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) IN SCAR RECTAL LESIONS: A RETROSPECTIVE STUDY FROM 2 REFERRAL THIRD LEVEL CENTERS
Authors: P. Biamonte, F.V. Mandarino, A. Barchi, F. Azzolini, E. Viale, D. Esposito, G. Dell'Anna, L. Fanti, P. Cecinato, R. Sassatelli, S. Danese
Journal: Endoscopy (2022)

Aims Aim of the study was evaluating efficacy and safety of hybrid vs traditional ESD treating scar rectal lesions.
FEASIBILITY OF FLUORESCENCE CONFOCAL MICROSCOPY FOR RAPID EVALUATION OF ENDOSCOPIC ULTRASOUND THROUGH THE NEEDLE BIOPSY IN PANCREATIC CYSTIC NEOPLASM: A PILOT STUDY
Authors: S. Stigliano, F.M. Di Matteo
Journal: Endoscopy (2022)

Aims Endoscopic ultrasound guided through-the-needle biopsy (EUS-TTNB) has improved the diagnostic algorithm of pancreatic cystic neoplasms (PCN). However, the fragments obtained are very small and sometimes not eye-visible with the risk of loss during the preparation process.
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial
Authors: Takayuki Yoshino, Eiji Oki, Toshihiro Misumi, Masahito Kotaka, Dai Manaka, Tetsuya Eto, Junichi Hasegawa, Akinori Takagane, Masato Nakamura, Takeshi Kato, Yoshinori Munemoto, Fumitaka Nakamura, Hiroyuki Bando, Hiroki Taniguchi, Yasuhiro Sakamoto, Manabu Shiozawa, Masayasu Nishi, Tetsuya Horiuchi, Hisakazu Yamagishi, Junichi Sakamoto, Tsunekazu Mizushima, Atsushi Ohtsu, Masaki Mori
Journal: Journal of Clinical Oncology (2022)

The phase III ACHIEVE trial conducted in Japan was one of six prospective studies included in the International Duration Evaluation of Adjuvant Therapy collaboration, which explored whether 3 months of adjuvant fluorouracil, leucovorin, and oxaliplatin (FOLFOX) or capecitabine and oxaliplatin (CAPOX) therapy would be noninferior to 6 months of treatment in patients with curatively resected stage III colon cancer. We report the final analyses of survival and long-term safety.Eligible patients were randomly assigned (1:1) to either 3 or 6 months of adjuvant chemotherapy (modified [m]FOLFOX6 or CAPOX, as selected by the treating physician). Random assignment was stratified according to number of involved lymph nodes, center, regimen, primary site, and age. The primary end point was disease-free survival, assessed in the modified intention-to-treat population. Overall survival (OS) was a secondary end point.The modified intention-to-treat population comprised 1,291 patients: 641 in the 6-month treatment group and 650 in the 3-month treatment group. Median follow-up for this analysis was 74.7 months. Five-year OS rates were comparable: 87.0% in the 3-month treatment group and 86.4% in the 6-month treatment group (hazard ratio, 0.91; 95% CI, 0.69 to 1.20; P = .51). Subgroup analysis of OS did not reveal a significant interaction between baseline characteristics and treatment duration. Peripheral sensory neuropathy lasting longer than 5 years was more common in the 6- compared with 3-month treatment group (16% v 8%, respectively), and in those receiving mFOLFOX6 compared with CAPOX (14% v 11%, respectively).In Asian patients, shortening adjuvant therapy duration from 6 to 3 months did not compromise efficacy and reduced the rate of long-lasting peripheral sensory neuropathy. In this setting, 3 months of CAPOX therapy is an appropriate adjuvant treatment option.
MOLECULAR ASPECT OF THE RESISTANCE OF HELICOBACTER PYLORI TO METRONIDAZOLE AND CLARITHROMYCIN AND ITS ASSOCIATION WITH THE VIRULENCE FACTOR CAG A IN A MOROCCAN POPULATION
Authors: I. Essaidi, I. Elyounsi, G. Bounder, M.R. Jouimyi, H. Boura, H. Benomar, K. Zerouali, F. Maachi
Journal: Endoscopy (2022)

Aims The aim of our study is to determine the prevalence of resistance of H. pylori to metronidazole and to clarithromycin in a Moroccan population infected with H. pylori and to study the impact of its virulence factor cagA on its resistance to antibiotics. .
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA
Authors: Daniel B. Mark, John A. Spertus, Robert Bigelow, Sophia Anderson, Melanie R. Daniels, Kevin J. Anstrom, Khaula N. Baloch, David J. Cohen, Claes Held, Shaun G. Goodman, Sripal Bangalore, Derek Cyr, Harmony R. Reynolds, Karen P. Alexander, Yves Rosenberg, Gregg W. Stone, David J. Maron, Judith S. Hochman
Journal: Circulation (2022)

Background: ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) compared an initial invasive treatment strategy (INV) with an initial conservative strategy in 5179 participants with chronic coronary disease and moderate or severe ischemia. The ISCHEMIA research program included a comprehensive quality-of-life (QOL) substudy. Methods: In 1819 participants (907 INV, 912 conservative strategy), we collected a battery of disease-specific and generic QOL instruments by structured interviews at baseline; at 3, 12, 24, and 36 months postrandomization; and at study closeout. Assessments included angina-related QOL (19-item Seattle Angina Questionnaire), generic health status (EQ-5D), depressive symptoms (Patient Health Questionnaire-8), and, for North American patients, cardiac functional status (Duke Activity Status Index). Results: Median age was 67 years, 19.2% were female, and 15.9% were non-White. The estimated mean difference for the 19-item Seattle Angina Questionnaire Summary score favored INV (1.4 points [95% CI, 0.2–2.5] over all follow-up). No differences were observed in patients with rare/absent baseline angina (SAQ Angina Frequency score &gt;80). Among patients with more frequent angina at baseline (SAQ Angina Frequency score &lt;80, 744 patients, 41%), those randomly assigned to INV had a mean 3.7-point higher 19-item Seattle Angina Questionnaire Summary score than conservative strategy (95% CI, 1.6–5.8) with consistent effects across SAQ subscales: Physical Limitations 3.2 points (95% CI, 0.2–6.1), Angina Frequency 3.2 points (95% CI, 1.2–5.1), Quality of Life/Health Perceptions 5.3 points (95% CI, 2.8–7.8). For the Duke Activity Status Index, no difference was estimated overall by treatment, but in patients with baseline SAQ Angina Frequency scores &lt;80, Duke Activity Status Index scores were higher for INV (3.2 points [95% CI, 0.6–5.7]), whereas patients with rare/absent baseline angina showed no treatment-related differences. Moderate to severe depression was infrequent at randomization (11.5%–12.8%) and was unaffected by treatment assignment. Conclusions: In the ISCHEMIA comprehensive QOL substudy, patients with more frequent baseline angina reported greater improvements in the symptom, physical functioning, and psychological well-being dimensions of QOL when treated with an invasive strategy, whereas patients who had rare/absent angina at baseline reported no consistent treatment-related QOL differences. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01471522.
INTRAGASTRIC BOTULINUM TOXIN-RELATED LARGE GASTRIC PHYTOBEZOAR REMOVED ENDOSCOPICALLY
Authors: M.U. Khan, K. Mushtaq, K. Al-Ejji, R. Yakoob
Journal: Endoscopy (2022)

Aims Endoscopic intra-Gastric botulinum toxin is one of the weight loss procedures with variable results. It may result in transient gastroparesis. Gastroparesis is a risk factor for bezoar formation. We present one of the first cases of gastric phytobezoar formation likely due to intragastric botulinum toxin injection-related transient gastroparesis.
OUTCOMES AFTER COLORECTAL ESD LEARNING WITH IN-ROOM “GUEST-EXPERT”. FEASIBILITY AND RESULTS OF A DOUBLE-OPERATOR ESD REGIONAL CENTRUM IN SOUTHEAST SWEDEN
Authors: G. Katinios, Y. Minato, M. Shafazand, S. Yamamoto, O. Bednarska
Journal: Endoscopy (2022)

Aims Colorectal ESD is a technically demanding procedure with a steep learning curve. Aim of this study is to evaluate the feasibility and outcomes of colorectal ESD after learning with a “guest-expert” in the room.
A RARE CASE OF BOWEL OBSTRUCTION
Authors: L.E. Zamora Nava, G. Miranda-Zazueta
Journal: Endoscopy (2022)

A 78 yo male present to the ER with abdominal pain and nausea, laboratories were unremarkable. CT scan evidenced a thickening of the proximal ileum. An anterograde enteroscopy was performed and a 2 cm ulcer was found in ileum. Pathology reported eosinophilic infiltrate (>50 eosinophiles per HPF). Parasites, bacteria, mycobacteria, and HIV were ruled out. Upper and lower endoscopy were performed. No eosinophiles were observed in samples of esophagus, stomach, and left colon. In the duodenum (54 Eo × HPF), right colon (31 Eo × HPF), and transversum (16 Eo × HPF) were observed. Diagnosis of eosinophilic enteritis was established.
SENSITIVITY OF FAECAL IMMUNOCHEMICAL TEST FOR COLORECTAL CANCER SCREENING AND RISK FACTORS FOR INTERVAL CANCER: A FRENCH POPULATION-BASED STUDY
Authors: M. Canévet, M. Pruvost-Couvreur, B. Badic, J. Brousse-Potocki, S. Le Reun, S. Bouzeloc, T. Kermarrec, J.-B. Nousbaum, M. Robaszkiewicz, N. Reboux, L. Quénéhervé
Journal: Endoscopy (2022)

Aims Faecal immunochemical test (FIT) is intended to detect pre-symptomatic lesions to reduce the incidence and mortality of colorectal cancer (CRC). The objectives of this study were to determine the FIT sensitivity, whether diagnostic circumstances had an impact on treatment and survival, and risk factors for interval cancer (IC).
DIAGNOSTIC VALUE OF A SENSITIVE NEXT GENERATION SEQUENCING PANEL WITH UNIQUE MOLECULAR IDENTIFIERS (UMIS) FOR EVALUATING ROUTINE EUS-FNA SMEARS OF SOLID PANCREATIC LESIONS
Authors: H.M. Schutz, R. Quispel, P.N. Atmodimedjo, K. Biermann, M. van Velthuysen, W.N. Dinjens, M.J. Bruno, L.M. van Driel
Journal: Endoscopy (2022)

Aims Detection of clonal mutations may be of additional value for EUS-guided FNA. The amount of tissue on smears is often limited. Standard targeted next generation sequencing (NGS) approaches lack sensitivity to detect mutations in little material. The aim of this study was to investigate the diagnostic value of a NGS panel with unique molecular identifiers (UMI-NGS) on smears from solid pancreatic lesions with various cytological gradings according to the Bethesda criteria.
IMPROVING OGD STANDARDS- A STEP IN THE RIGHT DIRECTION
Authors: E. Coleman, A. Mourad, F. Chedgy
Journal: Endoscopy (2022)

Aims The British Society of Gastroenterology (BSG) has developed quality standards for endoscopy including photo-documentation of 8 anatomical sites during oesophago-gastro-duodenoscopy (OGD). These standards have been established to improve early cancer recognition. It has also been shown that the use of pre-medication prior to endoscopy improves mucosal visibility which might improve diagnostic yield. The pre-gastroscopy drink used in our endoscopy department is simethicone and N-acetylcysteine. At Royal Sussex County Hospital, we assessed administration of a pre-gastroscopy drink prior to diagnostic OGD and compliance with BSG photo-documentation guidelines in era of digital image capture.
AN UNUSUAL CAUSE OF ABDOMINAL OBSTRUCTION IN A 10-YEAR-OLD BOY SUCCESSFULLY TREATED BY ENDOSCOPY
Authors: L. Héroin, P. Lafeuille, G. Rossignol, S. Heissat, R. Dubois, J. Rivory, M. Pioche
Journal: Endoscopy (2022)

We report the case of an upper GI obstruction due to an acute bleeding within a duodenal duplication cyst. We performed an endoscopic marsupialization of the cyst. Endoscopic ultrasound was performed : the cyst measured 7.4x4.4 cm with both solid and liquid components. It was punctured to put a guide wire inside. A colonoscope was then with a hood to perform an incision on top of the cyst, following the guidewire. After penetrating inside, a snare was used to remove the remaining clots. A double pigtail stent was placed. The patient was able to eat the following day.
TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung
Authors: Rinna Tei, Koji Iijima, Koji Matsumoto, Takao Kobayashi, Jyoti Lama, Elizabeth A. Jacobsen, Hirohito Kita
Journal: Journal of Allergy and Clinical Immunology (2021)
39P Understanding the crosstalk between micro-RNA and Wnt signaling cascade associated with the expression level of HOXB13 and SRC genes in female breast cancer
Authors: A.K. Khan, M.N. Faisal, B. Aslam, H. Anwar, H. Muzaffar, A. Roobi, N. Aslam, L. Majeed, S. Ali, J. Aslam, M. Mehmood, Q. Tanveer, A. Mahmood
Journal: Annals of Oncology (2022)
139P Breast cancer risk estimation (CanRisk tool) and perception in unaffected women with family history of breast cancer
Authors: T. Ramon y Cajal, À. Lopez-Fernandez, M. Pardo, E. Darder, E. Perez, A. Costal, A. Teule, A. Perez, M. Torres, R. Alfonso, A. Vallmajó, N. Tuset Der-Abrain, M. Cruellas Lapena, M. Espinosa-Bravo, O. Diez, C. Lázaro, L. Feliubadaló, G. Llort Pursals, J.M. Brunet Vidal, J. Balmaña
Journal: Annals of Oncology (2022)